CRO Intel

Dashboard Companies Opportunity Signals Clinical Trials Hiring Intelligence Funding Publications FDA Settings

Company Intelligence

Discover companies with clinical, regulatory and hiring signals
Total Companies

6,643

Company Clinical Trials FDA Signals Hiring Opportunity Confidence Last Seen
Pharmavite — — —
60
36% 		7/17/2026 View Intelligence
Pharmaxi — — —
60
36% 		7/17/2026 View Intelligence
Pharmayeda — — —
60
36% 		7/17/2026 View Intelligence
Pharmazz — — —
60
36% 		7/17/2026 View Intelligence
Pharmig - Gesundheitsziele Aus Dem Rahmen-pharmavertrag — — —
60
36% 		7/17/2026 View Intelligence
Phasebio Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Phathom Pharmaceuticals — — —
60
47% 		7/20/2026 View Intelligence
Pheast Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Phenex Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Phenomen Pharma — — —
60
36% 		7/17/2026 View Intelligence
Pheon Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Pherin Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Phio Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Phlow — — —
60
40% 		7/20/2026 View Intelligence
Phoenicis Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Phoenix Healthcare Solutions — — —
60
41% 		7/20/2026 View Intelligence
Phosphate Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Phost'in Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Photonpharma — — —
60
36% 		7/17/2026 View Intelligence
Phrixus Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Phrontline Biopharma — — —
60
36% 		7/17/2026 View Intelligence
Physicians Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Physicians Science & Nature — — —
60
40% 		7/20/2026 View Intelligence
Phytotech Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Piedmont Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Pierian Biosciences 2 trials — —
60
36% 		7/17/2026 View Intelligence
Pieris Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Pierre Fabre Pharma 3 trials — —
60
36% 		7/17/2026 View Intelligence
Pierre Fabre Pharma Austria — — —
60
36% 		7/17/2026 View Intelligence
Pierre Fabre USA — — —
60
42% 		7/20/2026 View Intelligence
Piezo Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Pikavation Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Pila Pharma — — —
60
36% 		7/17/2026 View Intelligence
Pilatus Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Pillway Health Pharmacy — — —
60
36% 		7/17/2026 View Intelligence
Pilnova Pharma — — —
60
40% 		7/20/2026 View Intelligence
Pinnacle Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Pinta Biotherapeutics — — —
60
36% 		7/17/2026 View Intelligence
Pinteon Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Pioneer Life Sciences — — —
60
42% 		7/20/2026 View Intelligence
Piper Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Piqur Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Piramal Critical Care — — —
60
42% 		7/20/2026 View Intelligence
Pivotal Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Placon Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Plains Welding Supply — — —
60
39% 		7/20/2026 View Intelligence
Planet (Anhui) Pharmaceutical — — —
60
42% 		7/20/2026 View Intelligence
Plasma Protein Therapeutics Association — — —
60
36% 		7/17/2026 View Intelligence
Pleopharma — — —
60
36% 		7/17/2026 View Intelligence
Pleryon Therapeutics (hangzhou) — — —
60
36% 		7/17/2026 View Intelligence
Showing 4651 - 4700 of 6,643 companies